May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Complications of Intravitreal Injection of Triamcinolone: A Long-Term Follow-Up Study
Author Affiliations & Notes
  • S. Ben Yahia
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • K. Hmidi
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • R. Kahloun
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • F. Amouri
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • A. Ladjimi
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • R. Messaoud
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • M. Khairallah
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • Footnotes
    Commercial Relationships S. Ben Yahia, None; K. Hmidi, None; R. Kahloun, None; F. Amouri, None; A. Ladjimi, None; R. Messaoud, None; M. Khairallah, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 269. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Ben Yahia, K. Hmidi, R. Kahloun, F. Amouri, A. Ladjimi, R. Messaoud, M. Khairallah; Complications of Intravitreal Injection of Triamcinolone: A Long-Term Follow-Up Study. Invest. Ophthalmol. Vis. Sci. 2007;48(13):269.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To report the complications of intravitreal triamcinolone (IVTA) after a long-term follow-up.

Methods:: The study included 79 phakic eyes of 70 patients who underwent IVTA (4 mg) and completed at least 12 months’ follow-up. Indications for triamcinolone injection included severe macular edema of various causes (72 eyes) and choroidal neovascularization associated with age-related macular degeneration (7 eyes). Seventy three eyes received one injection and the 6 remaining eyes two injections. Adverse events were recorded at each follow-up visit. Mean follow-up was 20 months (range, 12-48).

Results:: Complications of IVTA included significant progression of cataract in 51 eyes (64.6%), significant elevation of intraocular pressure (IOP) in 18 eyes (22.8%), pseudoendophthalmitis in three eyes (3.8%), and retinal detachment in one eye (1.3%). No case of endophthalmitis was recorded. Mean time to IOP elevation and cataract formation was one month and 13 months, respectively. Cataract surgery was performed in 35 eyes (44.3%) and was uneventful in all cases. Of 18 eyes with significant IOP elevation, 17 (94.4%) were managed with topical glaucoma medication and only one eye (5.6%) required a trabeculectomy. The three pseudoendophthalmitis were managed with medical treatment and the retinal detachment was successfully treated with vitrectomy.

Conclusions:: Adverse events, mainly cataract formation and IOP elevation, are common after IVTA. However, these complications can be reasonably managed in almost all cases. Patients should be monitored closely and treated appropriately, when necessary.

Keywords: cataract • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×